Skip to main content
. 2021 Jun 3;7:100126. doi: 10.1016/j.lanepe.2021.100126

Fig. 1.

Fig. 1

Study population of invasive pneumococcal disease cases from people ≥60 years old in Germany, 2018–2019. We used 928 cases in the full analysis for vaccine effectiveness calculations.